Denali Advisors Llc
Source: SEC Form 13F · as of Mar 2026Denali Advisors Llc holds 18 biotech & pharma companies tracked by BioSniper, totaling $41.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$41.7M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 9,292 | $8.5M |
| CAHCardinal Health Inc. | 39,216 | $8.3M |
| AMPHAmphastar Pharmaceuticals, Inc. | 266,465 | $5.2M |
| PMPhilip Morris International Inc | 14,263 | $2.4M |
| SIGASIGA TECHNOLOGIES INC | 436,887 | $2.3M |
| NVSNovartis AG | 13,593 | $2.1M |
| HRMYHarmony Biosciences Holdings, Inc. | 59,900 | $1.7M |
| PBIPROVENTION BIO, INC. | 149,840 | $1.7M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 29,313 | $1.6M |
| MCKMcKesson Corporation | 1,694 | $1.5M |
| AZNASTRAZENECA PLC | 7,319 | $1.4M |
| UTHRUNITED THERAPEUTICS Corp | 1,502 | $891K |
| PAHCPHIBRO ANIMAL HEALTH CORP | 15,949 | $882K |
| DVADaVita Inc. | 5,641 | $867K |
| GMOptec International, Inc. | 11,100 | $827K |
| JNJJOHNSON & JOHNSON | 3,265 | $798K |
| REGNREGENERON PHARMACEUTICALS, INC. | 500 | $386K |
| GEHCGE HealthCare Technologies Inc. | 5,100 | $363K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.